Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Germ Cell Neoplasia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01658436
What this trial is testing

BEZ235 Phase II Trial in Patients With Advanced Pancreatic Neuroendocrine Tumors (pNET) After Failure of mTOR Inhibitor Therapy.

Who this might be right for
Pancreatic Neuroendocrine Tumors (pNET)
Novartis Pharmaceuticals 31
Not applicableApproved For MarketingNCT00730444
What this trial is testing

Expanded Access Protocol for [123I]mIBG for Patients With Known or Suspected Neuroblastoma

Who this might be right for
Neuroblastoma
GE Healthcare
Not applicableStudy completedNCT01210209
What this trial is testing

Study of Blood Samples From Patients With Ewing Sarcoma and Their Relatives

Who this might be right for
Sarcoma
Institut Curie 350
Testing effectiveness (Phase 2)Active Not RecruitingNCT03175432
What this trial is testing

Bevacizumab and Atezolizumab With or Without Cobimetinib in Treating Patients With Untreated Melanoma Brain Metastases

Who this might be right for
BRAF V600 Wild TypeClinical Stage IV Cutaneous Melanoma AJCC v8Intracranial Melanoma+4 more
M.D. Anderson Cancer Center 29
Not applicableStudy completedNCT04789421
What this trial is testing

Advanced Non-invasive Diagnostics for Early Cutaneous Tumor Diagnosis, Clinical-therapeutic and Economic Management

Who this might be right for
Cutaneous Melanoma
Azienda Ospedaliero-Universitaria di Modena 3,248
Not applicableStudy completedNCT02527304
What this trial is testing

Adaptive Staged Stereotactic Body Radiation Therapy in Treating Patients With Spinal Metastases That Cannot Be Removed by Surgery

Who this might be right for
MelanomaMetastatic Malignant Neoplasm in the SpineRenal Cell Carcinoma+2 more
Albert Einstein College of Medicine 24
Testing effectiveness (Phase 2)Study completedNCT01681212
What this trial is testing

Phase 2 Study of Ipilimumab Plus Dacarbazine in Japanese Patients With Advanced Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 21
Not applicableStudy completedNCT04304300
What this trial is testing

Radiotherapy in IDH Mutated Glioma: Evaluation of Late Outcomes

Who this might be right for
Astrocytoma, Grade IIAstrocytoma, Grade IIIOligodendroglioma+1 more
Erasmus Medical Center 80
Not applicableEnrolling By InvitationNCT06703944
What this trial is testing

Risk Model for Metastasis Detection of Neuroblastoma

Who this might be right for
Neuroblastoma (NB)PrognosisBone Marrow Metastasis+1 more
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 500
Large-scale testing (Phase 3)Ended earlyNCT02443194
What this trial is testing

The Effect of Duloxetine on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients

Who this might be right for
Depression
michal roll 50
Testing effectiveness (Phase 2)WithdrawnNCT04713202
What this trial is testing

Prospective Assessment of Patients With Neuroendocrine Tumors and Current or Prior History of Carcinoid Syndrome or Diarrhea Undergoing Peptide Receptor Radionuclide Therapy With or Without Telotristat Ethyl

Who this might be right for
Neuroendocrine TumorsCarcinoid SyndromeDiarrhea
Chandrikha Chandrasekhara
Not applicableLooking for participantsNCT04793737
What this trial is testing

Precision Radiation of Immune Checkpoint Therapy Resistant Melanoma Metastases

Who this might be right for
Metastatic Melanoma
Karolinska University Hospital 27
Testing effectiveness (Phase 2)Looking for participantsNCT05896839
What this trial is testing

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+10 more
National Cancer Institute (NCI) 16
Testing effectiveness (Phase 2)Ended earlyNCT01216657
What this trial is testing

Trial of Single Agent Sunitinib for Patients With Chemo-refractory Metastatic Melanoma

Who this might be right for
Chemo-refractory Melanoma
Krankenhaus Nordwest 7
Large-scale testing (Phase 3)WithdrawnNCT01830101
What this trial is testing

A Phase III Study of Re-Irradiation in Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma
AHS Cancer Control Alberta
Large-scale testing (Phase 3)Study completedNCT02511405
What this trial is testing

A Phase 3, Pivotal Trial of VB-111 Plus Bevacizumab vs. Bevacizumab in Patients With Recurrent Glioblastoma (GLOBE)

Who this might be right for
Glioblastoma
Vascular Biogenics Ltd. operating as VBL Therapeutics 252
Testing effectiveness (Phase 2)Study completedNCT00923195
What this trial is testing

Radiation, Chemotherapy, Vaccine and Anti-MART-1 and Anti-gp100 Cells for Patients With Metastatic Melanoma

Who this might be right for
MelanomaSkin Cancer
National Cancer Institute (NCI) 4
Not applicableStudy completedNCT06358001
What this trial is testing

EchoTip AcuCore Post-Market Clinical Study

Who this might be right for
AdenocarcinomaNeuroendocrine TumorsHepatocellular Carcinoma+5 more
Cook Research Incorporated 183
Not applicableLooking for participantsNCT07078136
What this trial is testing

Multicenter Observational Study of Multimodal AI for Upper GI Mesenchymal Tumor Diagnosis

Who this might be right for
Submucosal TumorGastrointestinal Stromal Tumor (GIST)Leiomyoma+1 more
Huazhong University of Science and Technology 130
Testing effectiveness (Phase 2)Looking for participantsNCT06450041
What this trial is testing

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

Who this might be right for
Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium 62
Next Page